Free Trial
NASDAQ:TECX

Tectonic Therapeutic (TECX) Stock Price, News & Analysis

Tectonic Therapeutic logo
$40.45 -2.81 (-6.50%)
(As of 11/15/2024 ET)

About Tectonic Therapeutic Stock (NASDAQ:TECX)

Key Stats

Today's Range
$38.46
$42.98
50-Day Range
$17.50
$47.75
52-Week Range
$12.12
$48.63
Volume
131,606 shs
Average Volume
135,139 shs
Market Capitalization
$596.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$74.67
Consensus Rating
Buy

Company Overview

Avrobio, Inc. is a bio-technology company. It develops step-change cell and gene therapies for the treatment of cancer and rare disease. The company operates primarily in the United States and Canada. Avrobio, Inc. is based in MA, United States.

Tectonic Therapeutic Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
74th Percentile Overall Score

TECX MarketRank™: 

Tectonic Therapeutic scored higher than 74% of companies evaluated by MarketBeat, and ranked 306th out of 970 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Tectonic Therapeutic has received a consensus rating of Buy. The company's average rating score is 3.20, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Tectonic Therapeutic has only been the subject of 2 research reports in the past 90 days.

  • Read more about Tectonic Therapeutic's stock forecast and price target.
  • Earnings Growth

    Earnings for Tectonic Therapeutic are expected to grow in the coming year, from ($8.31) to ($5.10) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Tectonic Therapeutic is -6.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Tectonic Therapeutic is -6.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Tectonic Therapeutic has a P/B Ratio of 3.97. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Tectonic Therapeutic's valuation and earnings.
  • Percentage of Shares Shorted

    4.56% of the float of Tectonic Therapeutic has been sold short.
  • Short Interest Ratio / Days to Cover

    Tectonic Therapeutic has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tectonic Therapeutic has recently increased by 7.02%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Tectonic Therapeutic does not currently pay a dividend.

  • Dividend Growth

    Tectonic Therapeutic does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.56% of the float of Tectonic Therapeutic has been sold short.
  • Short Interest Ratio / Days to Cover

    Tectonic Therapeutic has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tectonic Therapeutic has recently increased by 7.02%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Tectonic Therapeutic has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for Tectonic Therapeutic this week, compared to 3 articles on an average week.
  • Search Interest

    14 people have searched for TECX on MarketBeat in the last 30 days.
  • MarketBeat Follows

    3 people have added Tectonic Therapeutic to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Tectonic Therapeutic insiders have bought more of their company's stock than they have sold. Specifically, they have bought $11,518,000.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 9.20% of the stock of Tectonic Therapeutic is held by insiders.

  • Percentage Held by Institutions

    62.63% of the stock of Tectonic Therapeutic is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Tectonic Therapeutic's insider trading history.
Receive TECX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tectonic Therapeutic and its competitors with MarketBeat's FREE daily newsletter.

TECX Stock News Headlines

Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up After Analyst Upgrade
2024 Election Year Stocks: Uncover Hidden Gems!
In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss.
See More Headlines

TECX Stock Analysis - Frequently Asked Questions

Tectonic Therapeutic's stock was trading at $16.10 at the beginning of the year. Since then, TECX stock has increased by 151.2% and is now trading at $40.45.
View the best growth stocks for 2024 here
.

Top institutional shareholders of Tectonic Therapeutic include FMR LLC (8.28%), Vida Ventures Advisors LLC (2.29%), Ikarian Capital LLC (1.81%) and BML Capital Management LLC (1.44%).
View institutional ownership trends
.

Shares of TECX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tectonic Therapeutic investors own include Waste Connections (WCN), iShares Micro-Cap ETF (IWC), The RMR Group (RMR), DiamondRock Hospitality (DRH), AUO (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM).

Company Calendar

Today
11/17/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
3/13/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TECX
Previous Symbol
NASDAQ:TECX
Fax
N/A
Employees
120
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$74.67
High Stock Price Target
$79.00
Low Stock Price Target
$69.00
Potential Upside/Downside
+84.6%
Consensus Rating
Buy
Rating Score (0-4)
3.20
Research Coverage
5 Analysts

Profitability

Net Income
$12.16 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$10.19 per share

Miscellaneous

Free Float
13,396,000
Market Cap
$596.64 million
Optionable
N/A
Beta
2.60
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:TECX) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners